Diametric Capital’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$209K	Sell	57,532 -153,793	-73%	-$560K	0.11%	251
2025 Q1	$406K	Buy	211,325 +123,210	+140%	+$237K	0.48%	66
2024 Q4	$167K	Buy	+88,115	New	+$167K	0.11%	250